(USD) | Dec 2023 | Q/Q |
---|---|---|
Revenue | 901.6MM | -2% |
Gross Profit | 526.2MM | -4% |
Cost Of Revenue | 375.4MM | +2% |
Operating Income | 245.3MM | -11% |
Operating Expenses | 280.9MM | - |
Net Income | 194.5MM | -8% |
R&D | 51.8MM | +8% |
G&A | 87MM | -2% |
Marketing | 142MM | +5% |
Interest Expense | 9.3MM | +7% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Fred Alger Management, an investment management company, released its “Alger Mid Cap Growth Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here. U.S. equities had a robust run in the fourth quarter, with the S&P Index finishing up 11.69%. The fund underperformed the Russell Midcap Growth Index in the quarter. […]
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on the bright side, you...
It is hard to get excited after looking at IDEXX Laboratories' (NASDAQ:IDXX) recent performance, when its stock has...
Executive Vice President James Polewaczyk has sold 8,104 shares of IDEXX Laboratories Inc (NASDAQ:IDXX) on March 6, 2024, according to a recent SEC filing.
Idexx (IDXX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Conestoga Capital Advisors, an asset management company, released its “Mid Cap Strategy” fourth-quarter 2023 investor letter. A copy of the same can be downloaded here. The Mid Cap Composite rose 11.00% net of fees in the fourth quarter, compared to a 14.55% return for the Russell Midcap Growth Index. Negative impacts from stock selection were outweighed by […]
WESTBROOK, Maine, February 20, 2024--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, will participate in two upcoming conferences:
In this article, we will be taking a look at the 25 most valuable medical device companies in the US. If you are not interested in learning about the emerging trend in medical device industry, head straight to the 5 Most Valuable Medical Device Companies In The US. In the dynamic healthcare technology landscape, the […]
IDEXX's (IDXX) Vello software is an intuitive solution designed specifically for practice management software that enables practitioners to interact with pet owners before and after visits.
Investors are optimistic about IDEXX (IDXX) growth in CAG business and strong global performance